‹ Back
Retatrutide · How it works
The glucagon signal
Retatrutide switches on the glucagon receptor, the arm that tirzepatide does not have. In the liver, glucagon turns on fat burning and ketone production and pulls stored fat out of liver cells. Across the body it raises energy use, so you burn more fuel at rest. The GLP-1 and GIP arms hold blood sugar steady while the glucagon arm burns fat, which is why the three together work better than any pair.
Sources
Read the original sources
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. (Coskun · 2022 · Abstract; full methods not assumed · checked 2026-10-13)
- Shared mechanistic pathways of glucagon signalling in obesity and fatty liver, Neff 2025, Diabetes Obes Metab (Abstract · checked 2026-10-13)
- Type 2 diabetes and obesity: the present and future of incretin therapy, Shestakova and Bashlykova 2025, Therapeutic Archive (Russia) (Summary · checked 2026-10-13)